Table 2 Cytoplasmic and membranous expression of ALCAM evaluated as immunoreactivity score in normal breast tissue, ductal carcinoma in situ, and invasive breast carcinoma.
ALCAM | Normal breast tissue (n = 137) | DCIS (n = 65) | Invasive carcinoma (n = 162) |
---|---|---|---|
IRS cytoplasmic | |||
median | 2 | 4 | 6 |
mean | 2.7 | 5.1 | 5.4 |
IRS membranous | |||
Median | 3 | 4 | 4 |
Mean | 3.2 | 4.9 | 4.7 |
ALCAM, activated leucocyte cell adhesion molecule; DCIS, ductal carcinoma in situ; IRS, immunoreactive score.